This review reveals how immune profiling technologies enhance cancer treatment and predicts patient responses, implying the need for better integration into clinical practice.
Key Points
Immune profiling offers insights for personalized cancer therapy and improved patient outcomes.
Technological innovations like mass cytometry and liquid biopsy help predict treatment responses effectively.
Integration of artificial intelligence with immune profiling can enhance predictive insights for clinical decision-making.
Challenges like data harmonization and sample variability need addressing to optimize cancer diagnostics.